Glutamine/infliximab/mesalazineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1947卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35341-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：201 / 201

相关论文

共 50 条

[31] Infliximab/tofacitinibLack of efficacy: case report
Reactions Weekly, 2021, 1836 (1) : 424 - 424
[32] Infliximab/methylprednisoloneLack of efficacy: case report
Reactions Weekly, 2021, 1865 (1) : 234 - 234
[33] Infliximab/steroidsLack of efficacy: case report
Reactions Weekly, 2023, 1976 (1) : 181 - 181
[34] Infliximab/methylprednisoloneLack of efficacy: case report
Reactions Weekly, 2022, 1928 (1) : 208 - 208
[35] Infliximab/vedolizumabLack of efficacy : case report
Reactions Weekly, 2024, 2019 (1) : 222 - 222
[36] Infliximab/steroidsLack of efficacy: case report
Reactions Weekly, 2020, 1835 (1) : 216 - 216
[37] Infliximab/sulfasalazineLack of efficacy: case report
Reactions Weekly, 2020, 1827 (1) : 184 - 184
[38] Infliximab/methylprednisoloneLack of efficacy: case report
Reactions Weekly, 2021, 1885 (1) : 272 - 272
[39] Infliximab/MethylprednisoloneLack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 473 - 473
[40] Infliximab/VedolizumabLack of efficacy: case report
Reactions Weekly, 2025, 2049 (1) : 186 - 186

← 1 2 3 4 5 →